Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
作者： Darcy A. Krueger , Angus A. Wilfong , Katherine Holland-Bouley , Anne E. Anderson , Karen Agricola
DOI: 10.1002/ANA.23960
关键词:
摘要: … Epilepsy is a major manifestation of tuberous sclerosis complex (TSC). Everolimus is an … TSC patients with medically refractory epilepsy following treatment with everolimus. Everolimus …
researchgate.net 
sci-hub.se 参考文章(46)
Peter B. Crino, Malformations of Cortical Development: Molecular Pathogenesis and Experimental Strategies Advances in Experimental Medicine and Biology. ,vol. 548, pp. 175- 191 ,(2004) , 10.1007/978-1-4757-6376-8_13
Jennifer A. Chan, Hongbing Zhang, Penelope S. Roberts, Sergiusz Jozwiak, Grajkowska Wieslawa, Joanna Lewin-Kowalik, Katarzyna Kotulska, David J. Kwiatkowski, Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Journal of Neuropathology and Experimental Neurology. ,vol. 63, pp. 1236- 1242 ,(2004) , 10.1093/JNEN/63.12.1236
Penny Prather, Petrus J. de Vries, Behavioral and cognitive aspects of tuberous sclerosis complex. Journal of Child Neurology. ,vol. 19, pp. 666- 674 ,(2004) , 10.1177/08830738040190090601
Petrus J. de Vries, Neurodevelopmental, Psychiatric and Cognitive Aspects of Tuberous Sclerosis Complex Tuberous Sclerosis Complex. pp. 229- 267 ,(2010) , 10.1002/9783527630073.CH12
C. Nicole Sunnen, Amy L. Brewster, Joaquin N. Lugo, Fabiola Vanegas, Eric Turcios, Shivani Mukhi, Deena Parghi, Gabriella D’Arcangelo, Anne E. Anderson, Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice Epilepsia. ,vol. 52, pp. 2065- 2075 ,(2011) , 10.1111/J.1528-1167.2011.03280.X
Emilio Russo, Rita Citraro, Giuseppe Donato, Caterina Camastra, Rodolfo Iuliano, Salvatore Cuzzocrea, Andrew Constanti, Giovambattista De Sarro, mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy Neuropharmacology. ,vol. 69, pp. 25- 36 ,(2013) , 10.1016/J.NEUROPHARM.2012.09.019
Finbar JK O'Callaghan, Alistair W Shiell, John P Osborne, Christopher N Martyn, Prevalence of tuberous sclerosis estimated by capture-recapture analysis. The Lancet. ,vol. 351, pp. 1490- ,(1998) , 10.1016/S0140-6736(05)78872-3
Long-Ze Sha, Xiao-Liang Xing, Dan Zhang, Yuan Yao, Wan-Chen Dou, Li-Ri Jin, Li-Wen Wu, Qi Xu, Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy PLoS ONE. ,vol. 7, pp. e39152- ,(2012) , 10.1371/JOURNAL.PONE.0039152
L.-H. Zeng, N. R. Rensing, M. Wong, The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy The Journal of Neuroscience. ,vol. 29, pp. 6964- 6972 ,(2009) , 10.1523/JNEUROSCI.0066-09.2009
Michael G Aman, Marc J Tassé, Johannes Rojahn, David Hammer, The Nisonger CBRF: A Child Behavior Rating Form for Children with Developmental Disabilities. Research in Developmental Disabilities. ,vol. 17, pp. 41- 57 ,(1996) , 10.1016/0891-4222(95)00039-9